4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-26-000002
Chief Scientific Officer sold 13,000 shares at $2.69 ($34,953)
- Chief Scientific Officer acquired 13,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2026-01-08 | Option exercise 10b5-1 | +13,000 | $0.06 | $780 | 13,000 | D |
| Moreadith Randall Chief Scientific Officer | 2026-01-08 | Sale 10b5-1 | −13,000 | $2.69 | $34,953 | 0 | D |
| Derivatives | |||||||
| Moreadith Randall Chief Scientific Officer | 2026-01-08 | Option exercise · Stock Option (right to buy) 10b5-1 | −13,000 | 339,186 | D | ||
| Open-market sales · 13,000 sh · avg $2.69 · $34,953 | |||||||
Loading xslF345X05/wk-form4_1767979647.xml…